| Factor Information | |
|---|---|
| Data ID | 3171 |
| Factor | β-blocker at administration of sotalol (n) |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | The purpose of this study was to assess the efficacy and safety of sotalol for refractory tachyarrhythmias in patients with CHD. |
| p Value | 0.0166 |
| Conclusion | Sotalol is partially or completely effective for refractory tachyarrhythmias in patients with CHD, and non-pharmacological interventions improve the efficacy of sotalol. This multimodal approach should be considered in patients with refractory tachyarrhythmias and CHD |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 659 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
| Reference | |
|---|---|
| PMID | 18931451 |
| Year | 2008 |
| Title | Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease |
| Sample | ||
|---|---|---|
| Population | adolescent and adult | |
| Source | patients' data | |
| Region | Suita, Japan | |
| Method | 2-tailed unpaired student's t-test | |
| Race | Japanese | |
| Disease History | N/A | |
| Treatment History | surgery | |
| Group | N/A(Treatment) | N/A(Control) |
| Number | N/A | N/A |
| Age | mean age=23±12 years(range: 0.1-42 years) | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | total=14(32%), complete control=3(17%), partial control=9(60%), failure=2(18%) | N/A |
